Physical relaxation and a subjective reduction in stress are the most common reports about cannabigerol, with no associated psychoactive effects. A controlled trial using 20 mg of CBG measured a 26.5% reduction in subjective anxiety in healthy adults, a notable result but one that remains isolated in the human literature. The following sections detail the reported effects, the mechanisms involved, and precautions to be aware of before using it.


In short:

  • A 20 mg dose of CBG can reduce subjective anxiety by approximately 26.5% without causing a high or impaired motor function.
  • CBG acts as a partial agonist of CB1 and CB2 receptors, which promotes a more direct action on the body, particularly on the physical symptoms of stress.
  • The strongest clinical evidence relates to a single trial with a single dose of 20 mg, but few long-term or large-scale studies have yet confirmed its effects in humans.
  • Most reported effects include muscle relaxation, a decrease in mental tension, and a slight improvement in verbal memory, without euphoria.
  • The quality of the product is based on a reliable certificate of analysis, the origin of the hemp and compliance with the legal THC threshold, essential to guarantee safety and effectiveness.

Table of Contents

What are the common side effects of CBG?

User feedback and limited clinical data point to a fairly consistent profile: noticeable muscle relaxation, a decrease in mental tension, and a feeling of calm without impaired lucidity. This last point clearly distinguishes CBG from THC, with which it should not be confused despite their chemical similarity.

Anxiety and stress. This is the best-documented effect. In the randomized, double-blind trial conducted in 2024, a single 20 mg dose produced a measurable reduction in perceived stress, without causing any sensation of intoxication in the participants.

In figures: 26.5% reduction in subjective anxiety after 20 mg of CBG, compared to placebo, in a crossover protocol in real-world conditions.

Pain and inflammation. The signals come mainly from preclinical studies and user feedback; there are no large-scale human trials yet on this specific point. People who use it for mild chronic pain often describe a gradual easing rather than immediate relief.

Digestive comfort. In vitro studies suggest an effect on intestinal motility, an area that preclinical research continues to explore. User feedback indicates a reduction in bloating for some consumers, although this observation cannot be generalized.

Memory and cognition. The 2024 trial also noted an improvement in verbal memory among participants who received CBG, a result that contrasts with the sometimes blurry image associated with cannabinoids.

Here are the key points to remember regarding the reported sensations:

  • Muscle relaxation and a decrease in nervous tension, often described as progressive.
  • No euphoria or altered perception, unlike with THC.
  • Occasional improvement in verbal memory observed under controlled conditions.
  • Digestive and anti-inflammatory effects mainly documented in preclinical studies, to be confirmed in humans.

This picture remains consistent with what we know about CBD and its effect on daily well-being, even if the two molecules do not act through the same pathways, as we will see.

Why does CBG act differently from CBD?

The distinct effects of CBG are explained by specific pharmacological mechanisms, which recent reviews are beginning to better understand. CBG acts as a partial agonist of the CB1 and CB2 receptors of the endocannabinoid system, whereas CBD acts more as an allosteric modulator and indirect antagonist of these same targets.

This difference in mechanism partly explains why the two molecules produce similar but not identical sensations:

  • CBG partially activates CB1/CB2 receptors, which could promote a more direct action on physical stress.
  • Its interaction with 5-HT1A serotonergic receptors contributes to the anxiolytic effect observed in clinical trials.
  • It inhibits the reuptake of anandamide, a natural endocannabinoid, potentially prolonging its action in the body.
  • Its affinity for alpha-2 adrenergic receptors could explain a perceived effect on the physical symptoms of stress, such as palpitations or muscle tension.

These mechanisms, described in pharmacological reviews on cannabinoid compounds, suggest that CBG primarily targets the physical manifestations of stress. CBD, on the other hand, appears to act more on the cognitive component of anxiety, according to a comparative analysis published by Newsweed. This complementarity fuels interest in CBG and CBD combinations, a point we will explore further below.

What do studies on CBG say in light of user feedback?

The most robust trial available to date remains the double-blind crossover study conducted in 2024, which tested a single 20 mg dose of hemp-derived CBG in healthy adults. The crossover design allows each participant to serve as their own control, thus enhancing statistical reliability despite a limited sample size.

Criteria Observation
Type of study Randomized, placebo-controlled, double-blind, crossover trial
Dose tested 20 mg of CBG, single dose
Result on anxiety Subjective reduction of 26.5% compared to placebo
Motor effects/intoxication No significant alterations detected
Main limit Single dose, limited sample size, no long-term follow-up

The authors of the trial note that CBG reduced perceived stress and anxiety without producing any measurable motor alteration, a result that clearly distinguishes this cannabinoid from classic psychoactive substances.

Apart from this trial, the majority of data on CBG comes from preclinical studies conducted on animal models or in vitro work. This research explores promising avenues (inflammation, digestive motility, neuroprotection) but does not yet allow for conclusions that can be generalized to humans. The gap between the wealth of preclinical hypotheses and the scarcity of clinical trials constitutes the main limitation of the field of CBG research today.

What dose and form of CBG are needed to experience its effects?

Unlike some medications with regulated dosages, there is no officially approved dosage for CBG. The landmark clinical trial used a single 20 mg dose, but this dose is not a general recommendation applicable to all patients.

  1. Vaporization : the effects can appear within minutes, but their duration remains shorter.
  2. Sublingual route (oil under the tongue): effects felt between 20 and 60 minutes, for an intermediate duration.
  3. Ingestion (capsules, edible products): onset of action takes 30 to 120 minutes, with effects generally longer but more variable.

The experience also depends on body weight, metabolism and the spectrum of the product chosen (full spectrum, broad spectrum or isolate), as the terpenes present in some hemp flowers can modulate the perceived intensity.

Pro tip: Always start with a small dose, note how you feel for a few days, then gradually increase until you find the right dose for you. This empirical approach remains the most reliable in the absence of an official dosage consensus.

What side effects and precautions should you be aware of?

CBG is generally well tolerated, but some side effects are reported in user feedback: dry mouth, mild drowsiness, and sometimes mild digestive upset. These effects remain moderate in most users, but they warrant particular attention for certain individuals.

  • Cannabinoids can interact with liver metabolism via cytochrome P450 enzymes, which may alter the effectiveness of certain medications, including anticoagulants.
  • Pregnant or breastfeeding women should avoid CBG due to a lack of sufficient safety data on these populations.
  • People undergoing chronic treatment (anticoagulants, antiepileptics) should talk to a doctor before taking any medication, as interaction remains possible even without psychoactive effects.
  • Keeping a journal of how you feel helps to quickly identify an undesirable effect and to adjust or stop consumption if necessary.

The cannabinoid safety prevention guide details these at-risk populations in more depth.

How to identify a reliable CBG product before buying?

The quality of a CBG product is primarily verified by its Certificate of Analysis (COA), issued by an independent laboratory. This document confirms the actual concentration of cannabinoids and the absence of solvent or heavy metal residues, two criteria that reputable sellers systematically provide.

  • Check that the COA figures match those advertised on the product label.
  • Find out about the origin of the hemp and the extraction method used, with supercritical CO2 extraction generally considered the cleanest.
  • Identify the type of spectrum (full spectrum, broad spectrum or isolate) and check the THC level, which must remain below the legal threshold of 0.3%.
  • To start, opt for an oil or tincture, the dosage of which is easier to adjust than with a flower or resin.
Item to check Why this is important
Certificate of Analysis (COA) Confirms the actual CBG content and the absence of contaminants
Origin of hemp Influences the quality and traceability of the final product
Spectrum type Determines the presence of other cannabinoids and residual THC
Starting format An oil allows for a more gradual dosage than a flower

Why traceability matters as much as feelings

A positive feeling is worthless if the product providing it isn't compliant with regulations. Thefrenchhempempire publishes independent laboratory analyses of its product range, allowing customers to verify the accuracy of the labeling and the actual contents of each product. This transparency aligns with the criteria mentioned earlier for choosing a quality CBG product.

The brand's educational blog also offers additional resources, particularly on the differences between CBG, CBN and CBD, to help readers place each cannabinoid in their wellness routine.

Why traceability matters as much as perception — overview diagram

When should you consider CBG in a wellness routine?

CBG is useful during periods of occasional stress, or for persistent physical tension such as muscle stiffness. Its lack of a psychoactive effect makes it a suitable option for daytime use, unlike more sedative products.

The association with CBD, often referred to as the entourage effect, remains plausible from a mechanistic standpoint but has not yet been validated by dedicated randomized trials. Any chronic condition or medication warrants medical advice before starting, regardless of the cannabinoid being considered.

— Vanessa

Where do you start if you want to try CBG?

Unlike poorly dosed formulas or vague claims sometimes found online, every Thefrenchhempempire product comes with its own independent certificate of analysis, allowing you to verify the exact concentration of CBG before you even place an order.

Thefrenchhempempire

For a first try, an oil allows you to adjust the dose to the milliliter, a real advantage when you're still finding your personal limit. The page "CBG, CBN, and CBD: Differences, Effects, and Uses" lists the available products and details the cannabinoid levels of each, with strict compliance to the legal THC limit of 0.3% and discreet delivery throughout Europe. Consult this page to compare options and choose the format that suits your consumption habits.

This article provides general information and is not a substitute for professional medical advice. Consult a qualified healthcare professional about your specific situation before taking any action based on this content.

Sources

Recommendations

Vanessa

I'm Vanessa, a writer specializing in topics related to hemp, CBD, and legal cannabis. For several years, I've been interested in market trends, cannabinoids, French and European regulations, and the challenges of quality, traceability, and safety for consumers. Through my articles, my goal is to provide clear, verified, and accessible information to help everyone better understand the world of CBD and hemp-derived products. Each article is written using official, scientific, or regulatory sources when the topic requires it.